buthionine sulfoximine glutathione synthesis inhibitor Iron-based metal-organic framework co-loaded with and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable elimination | Journal of Nanobiotechnology Full article: Redox enzyme networks
Full article: Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways DL Buthionine sulfoximine Frontiers Systemic L Buthionine S R Sulfoximine Treatment Increases Plasma NGF and Upregulates L cys L cys2 Transporter and Glutamylcysteine Ligase mRNAs Through the NGF TrkA Akt Nrf2 Pathway in the Striatum
Pay in 4 interest-free payments of $5.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



